Reaction
Heart Transplant Rejection reporting signals
As of the last recalculation, Heart Transplant Rejection appears in 1,032 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is ANTI-THYMOCYTE GLOBULIN (RABBIT) (PRR 398.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anti-Thymocyte Globulin (Rabbit) | 138 | 398.1 | 405.1 |
| Tacrolimus | 619 | 197.7 | 198.5 |
| Mycophenolate Mofetil | 557 | 178.5 | 179.3 |
| Mycophenolate Mofetil Hydrochloride | 557 | 178.2 | 178.9 |
| Tacrolimus Extended-Release Capsules | 495 | 152.7 | 153.3 |
| Tacrolimus Ointment 0.1% | 494 | 152.6 | 153.2 |
| Sirolimus | 48 | 75.3 | 75.6 |
| Mycophenilic Acid | 61 | 63.0 | 63.2 |
| Basiliximab | 35 | 62.1 | 62.3 |
| Everolimus Tablets | 49 | 61.8 | 62.0 |
| Mycophenolic Acid | 76 | 51.6 | 51.7 |
| Valganciclovir | 40 | 44.5 | 44.6 |
| Valganciclovir Hydrochloride | 40 | 44.5 | 44.6 |
| Valganciclovir Hydrochloride Powder, | 24 | 40.6 | 40.7 |
| Cyclosporine | 182 | 39.8 | 39.9 |
| Abacavir Sulfate | 12 | 25.1 | 25.2 |
| Everolimus | 53 | 22.1 | 22.1 |
| Itraconazole | 11 | 19.2 | 19.2 |
| Azathioprine | 75 | 18.4 | 18.5 |
| Drs. Clotrimazole | 10 | 17.6 | 17.6 |
| Family Wellness Clotrimazole | 10 | 17.6 | 17.6 |
| Clotrimazole Topical | 10 | 17.6 | 17.6 |
| Atazanavir | 12 | 17.0 | 17.0 |
| Zidovudine | 11 | 16.8 | 16.8 |
| Clotrimazole | 10 | 16.6 | 16.6 |
| Ritonavir 100 Mg | 12 | 16.4 | 16.4 |
| Raltegravir | 13 | 16.1 | 16.1 |
| Darunavir | 11 | 14.8 | 14.8 |
| Ganciclovir | 7 | 13.9 | 13.9 |
| Ganciclovir Sodium | 7 | 13.4 | 13.4 |
| Atovaquone | 5 | 12.6 | 12.6 |
| Lamivudine Oral | 14 | 11.3 | 11.3 |